Related Experiment Videos
Ovarian follicle development requires Smad3
Dragana Tomic1, Kimberly P Miller, Hilary A Kenny
1Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Molecular Endocrinology (Baltimore, Md.)
|June 12, 2004
Summary
Smad3 deficiency impairs female fertility in mice by disrupting ovarian folliculogenesis, leading to reduced follicle growth, increased atresia, and altered differentiation. These molecular changes ultimately prevent ovulation and egg development.
Area of Science:
- Reproductive Biology
- Molecular Endocrinology
- Cellular Signaling
Background:
- The Transforming Growth Factor beta (TGF-β) signaling pathway is crucial for various biological processes.
- Smad3 is a key mediator in the TGF-β pathway, and its deficiency (Smad3-/-) is linked to reduced fertility in mice.
- Understanding the molecular basis of impaired fertility in Smad3-/- mice requires investigating folliculogenesis.
Purpose of the Study:
- To test the hypothesis that Smad3 deficiency interferes with follicle growth, atresia, and differentiation.
- To elucidate the molecular mechanisms underlying reduced fertility in Smad3-/- mice.
- To assess the impact of Smad3 deficiency on hormone levels and ovulation capacity.
Main Methods:
- Compared follicle size, proliferation markers (PCNA), and cell cycle gene expression in Smad3-/- and wild-type (WT) mice.
- Assessed follicle atresia and expression of apoptosis-related genes (bcl-2 family) in Smad3-/- and WT mice.
- Evaluated differentiation markers (FSHR, ERα, ERβ, inhibins) and hormone levels (estradiol, FSH, LH) in both groups.
- Determined ovulation rates by counting corpora lutea and ovulated eggs after gonadotropin stimulation.
Main Results:
- Smad3 deficiency resulted in smaller follicle diameters, reduced PCNA, and decreased expression of cell cycle genes (CDK4, cyclin D2), indicating impaired growth.
- Smad3-/- mice exhibited increased follicle atresia, oocyte degeneration, and reduced expression of bcl-2, suggesting enhanced cell death.
- Follicular differentiation was affected, with decreased ERβ, increased ERα, and reduced inhibin α expression. Estradiol levels were low, while FSH levels were high.
- Smad3-/- ovaries lacked corpora lutea and failed to ovulate following gonadotropin treatment.
Conclusions:
- Reduced fertility in Smad3-/- mice is attributed to impaired folliculogenesis, characterized by compromised follicle growth, increased atresia, and altered differentiation.
- Altered gene expression related to cell cycle, cell survival, and differentiation underlies the observed fertility defect.
- The data suggest a potential interaction between Smad3 and FSH signaling downstream of the FSH receptor in the mouse ovary.